{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:04:36Z","timestamp":1762542276834},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T00:00:00Z","timestamp":1404345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00277-014-2145-6","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T09:21:41Z","timestamp":1404292901000},"page":"1985-1992","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Long-term efficacy of 90Y ibritumomab tiuxetan therapy in follicular non-Hodgkin lymphoma and health-related quality of life"],"prefix":"10.1007","volume":"93","author":[{"given":"Marcio Miguel","family":"Andrade-Campos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anel E.","family":"Montes-Lim\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Soro-Alcubierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Grasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Lopez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Baringo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Giraldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,3]]},"reference":[{"key":"2145_CR1","unstructured":"Leukemia and Lymphoma Society. Facts 2012. Statistics Review. (2012) http:\/\/www.lls.org\/content\/nationalcontent\/resourcecenter\/freeeducationmterial\/generalcancer\/pdf\/facts.pdf . Accessed 22 April 2014"},{"key":"2145_CR2","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"The Non-Hodgkin\u2019s Lymphoma Classification Project","year":"1997","unstructured":"The Non-Hodgkin\u2019s Lymphoma Classification Project (1997) A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma. Blood 89:3909","journal-title":"Blood"},{"key":"2145_CR3","volume-title":"Basic principles and practice of hematology","author":"R Hoffman","year":"2009","unstructured":"Hoffman R, Furie B, Benz EJ, McGlave P, Silberstein LE, Shattil S (2009) Basic principles and practice of hematology, 5th edn. ED Elsevier, Amsterdam","edition":"5"},{"key":"2145_CR4","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1200\/JCO.1996.14.4.1282","volume":"14","author":"MP Mac Manus","year":"1996","unstructured":"Mac Manus MP, Hoppe RT (1996) Is radiotherapy curative for stage I and II lowgrade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 14:1282\u20131290","journal-title":"J Clin Oncol"},{"key":"2145_CR5","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","volume":"351","author":"SS Dave","year":"2004","unstructured":"Dave SS, Wright G, Tan B et al (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351:2159","journal-title":"N Engl J Med"},{"key":"2145_CR6","doi-asserted-by":"crossref","unstructured":"Solal-C\u00e9ligny P, Bellei M, Marcheselli L, Pesce EA, Pileri S, McLaughlin P, Luminari S, Pro B, Montoto S, Ferreri AJ, Deconinck E, Milpied N, Gordon LI, Federico M. Watchful waiting in low\u2013tumor burden follicular lymphoma in the rituximab era: Results of an F2-Study Database JCO JCO.2010.33.4474; published online on September 24, 2012","DOI":"10.1200\/JCO.2010.33.4474"},{"issue":"5","key":"2145_CR7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/CCO.0b013e328356898b","volume":"24","author":"CA Jacobson","year":"2012","unstructured":"Jacobson CA, Freedman AS (2012) Early stage follicular lymphoma, current management and controversies. Curr Opin Oncol 24(5):475\u2013479","journal-title":"Curr Opin Oncol"},{"issue":"5 Suppl 14","key":"2145_CR8","first-page":"58","volume":"26","author":"OW Press","year":"1999","unstructured":"Press OW (1999) Review radiolabeled antibody therapy of B-cell lymphomas. Semin Oncol 26(5 Suppl 14):58\u201365","journal-title":"Semin Oncol"},{"issue":"2","key":"2145_CR9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.beha.2011.03.005","volume":"24","author":"T Illidge","year":"2011","unstructured":"Illidge T, Morschhauser F (2011) Radioimmunotherapy in follicular lymphoma. Best Pract Res 24(2):279\u2013293","journal-title":"Best Pract. Res"},{"issue":"10","key":"2145_CR10","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1200\/JCO.2002.11.076","volume":"20","author":"TE Witzig","year":"2002","unstructured":"Witzig TE, Gordon LI, Cabanillas F, Czuczman MS, Emmanouilides C, Joyce R, Pohlman BL, Bartlett NL, Wiseman GA, Padre N, Grillo-L\u00f3pez AJ, Multani P, White CA (2002) Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin\u2019s lymphoma. J Clin Oncol 20(10):2453\u20132463","journal-title":"J Clin Oncol"},{"key":"2145_CR11","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1200\/JCO.2008.17.2015","volume":"26","author":"F Morschhauser","year":"2008","unstructured":"Morschhauser F, Radford J, Van Hoof A, Vitolo U, Soubeyran P, Tilly H, Huijgens PC, Kolstad A, D\u2019Amore F, Gonzalez GM, Petrini M, Sebban C, Zinzani PL, van Oers MHJ, van Putten W, Bischof-Delaloye A, Rohatiner A, Salles G, Kuhlmann J, Hagenbeek A (2008) Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma. J Clin Oncol 26:5156\u20135164","journal-title":"J Clin Oncol"},{"key":"2145_CR12","doi-asserted-by":"crossref","unstructured":"Andrade Campos MM, Montes Lim\u00f3n AE, Grasa JM, Lievano P, Baringo T, Giraldo P. RIT with Y90-Ibritumomab Tiuxetan in follicular non-Hodgkin lymphoma: evaluation of recent outcomes in a single institution. J Oncol. 2012;2012:412742. Epub 2012 Sep 25","DOI":"10.1155\/2012\/412742"},{"key":"2145_CR13","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1200\/JCO.2009.26.8748","volume":"28","author":"TM Illdge","year":"2010","unstructured":"Illdge TM (2010) Radioimmunotherapy of lymphomas: a treatment approach ahead of its time or past its sell by date? J Clin Oncol 28:2944\u20132946","journal-title":"J Clin Oncol"},{"key":"2145_CR14","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2967\/jnumed.107.043489","volume":"48","author":"J Tennvall","year":"2007","unstructured":"Tennvall J, Fischer M, Bischof Delaloye A et al (2007) EANM procedure guideline for radio-immunotheapy for B-cell lymphoma with 90Y-radiolabelled ibritumumab tiuxetan (Zevalin\u00ae). Eur J Nucl Med 48:1767\u20131776","journal-title":"Eur J Nucl Med"},{"key":"2145_CR15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2967\/jnumed.108.055376","volume":"50","author":"HA Jacene","year":"2009","unstructured":"Jacene HA, Filice R, Kasecam W, Wahl R (2009) 18\u00a0F-DG PET\/CT for monitoring the response of lymphoma to radioimmunotherapy. J Nucl Med 50:8\u201317","journal-title":"J Nucl Med"},{"key":"2145_CR16","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.1158\/1078-0432.CCR-13-1511","volume":"19","author":"J Pyo","year":"2013","unstructured":"Pyo J, Kim KW, Jacene HA, Sakellis C, Brown J, Abbeele V d (2013) A end-therapy positron emission tomography for treatment response assesment in folicular lymphoma: a systematic review and meta-analysis. Clin Cancer Res 19:6566\u20136577","journal-title":"Clin Cancer Res"},{"key":"2145_CR17","first-page":"349","volume":"1","author":"NK Aaronson","year":"1992","unstructured":"Aaronson NK, Acquadro C, Alonso J et al (1992) International quality of life assessment (IQOLA) project. Quall IFE rES 1:349\u2013351","journal-title":"Quall IFE rES"},{"key":"2145_CR18","first-page":"771","volume":"104","author":"J Alonso","year":"1995","unstructured":"Alonso J, Prieto L, Ant\u00f3 JM (1995) La Version espa\u00f1ola del SF-36 health survey (Cuestionario de Salud SF-36): un instrumento para la medida de los resultados. Med Clin (Barc) 104:771\u2013776","journal-title":"Med Clin (Barc)"},{"key":"2145_CR19","unstructured":"Costa-Requena G, Gil F. Quality of life in the chemotherapy treatment of Spanish cancer patients: a comparison of general population norms"},{"key":"2145_CR20","unstructured":"Herce-Lopez J, Rollon-Mayordomo A, Lozano-Rosado R, Infante-Cossio P, Salazar-Fernandez CI. Assessment of quality of life of oral cancer survivors compared with Spanish populations norms"},{"issue":"5","key":"2145_CR21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/PPO.0b013e31826aed4f","volume":"18","author":"L Lowry","year":"2012","unstructured":"Lowry L, Ardeshna KM (2012) Has single-agent rituximab replaced watch-and-wait for patient with asymptomatic low-grade follicular lymphoma? Cancer J 18(5):390\u2013395","journal-title":"Cancer J"},{"issue":"6","key":"2145_CR22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.clml.2012.09.012","volume":"12","author":"AC Rose","year":"2012","unstructured":"Rose AC, Shenoy PJ, Garett G et al (2012) A systematic literature review and meta-analysis of radioimmunotherapy consolidation for patients with untreated follicular lymphoma. Clin Lymphoma Myeloma Leuk 12(6):393\u2013399","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2145_CR23","doi-asserted-by":"crossref","unstructured":"Mourschhauser F, Radford J, Van Hoof A, et al.: 90Ytrium-Ibritumomab Tiuxetan Consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: updated results after a median follow-up of 7.3 years from the International, Randomized, Phase III First-Line Indolent Trial. J Clin Oncol 2013(Published ahead of print on April 1, 2013 JCO.2012.45.6400","DOI":"10.1200\/JCO.2012.45.6400"},{"key":"2145_CR24","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.2967\/jnumed.111.089920","volume":"52","author":"K Hohloch","year":"2011","unstructured":"Hohloch K, Bischof Delaloye A, Windemuth-Kiesselbach C et al (2011) Radioimmunotherapy confers long-term survival to lymphoma patients with acceptable toxicity: registry analysis by the international radioimmunothrapy network. J Nucl Med 52:1354\u20131360","journal-title":"J Nucl Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2145-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-014-2145-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2145-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T21:59:23Z","timestamp":1598047163000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-014-2145-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,3]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2145"],"URL":"https:\/\/doi.org\/10.1007\/s00277-014-2145-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,3]]}}}